Volver al buscador
FDAFDA · Alimentos y medicamentos·N.º oficial Z-0531-2014

Viscocel and Viscocel Plus. These products are intraocular fluid devices consisting of non-gaseous fluid intended to be introduced into the eye to aid performance of surgery, such as to maintain anterior chamber depth, preserve tissue integrity, protect tissue from surgical trauma, or function as a tamponade during retinal reattachment.

Publicado el 1 de enero de 2014 · Inicio del retiro: 25 de noviembre de 2013

Resumen

FDA registra el retiro Z-0531-2014 de dispositivos médicos de Clase I, publicado el 1 de enero de 2014 e iniciado el 25 de noviembre de 2013. Empresa responsable: C.L.R. Medicals International, Inc.; Estado: Finalizado; Cantidad reportada: 249,592 units; Lote: All lots manufactured September 01, 2011 to September 19, 2013. La Clase I indica una probabilidad razonable de consecuencias graves para la salud o muerte.

Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.

Qué peligro representa

CLR Medicals International Inc., initiated a nationwide recall of Viscocel and Viscocel Plus, in response to FDA inspection findings of deficiencies in the Quality System Regulations for Medical Device Manufacturers, 21 Code of Federal Regulation (CFR) Part 820 and lack of Premarket Approval (PMA) for devices sold or distributed in domestic commerce. The Viscoelastic products, intended for human

Qué hacer

Voluntary: Firm initiated · Press Release

Recibe un correo cuando FDA publique un retiro como este

Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.

Detalles del retiro

Fabricante
C.L.R. Medicals International, Inc.
Distribuidor
Worldwide Distribution - USA (nationwide) and Internationally to Egypt, Mexico, and Canada.
Lote
All lots manufactured September 01, 2011 to September 19, 2013.
Clasificación de riesgo
Class I
Área (FDA)
device
País
United States

Retiros relacionados

Preguntas sobre este retiro

¿Viscocel and Viscocel Plus. These products are intraocular fluid devices consisting of non-gaseous fluid intended to be introduced into the eye to aid performance of surgery, such as to maintain anterior chamber depth, preserve tissue integrity, protect tissue from surgical trauma, or function as a tamponade during retinal reattachment. fue retirado del mercado?

Sí. FDA publicó el retiro Z-0531-2014 el 1 de enero de 2014. Peligro reportado: CLR Medicals International Inc., initiated a nationwide recall of Viscocel and Viscocel Plus, in response to FDA inspection findings of deficiencies in the Quality System Regulations for Medical Device Manufacturers, 21 Code of Federal Regulation (CFR) Part 820 and lack of Premarket Approval (PMA) for devices sold or distributed in domestic commerce. The Viscoelastic products, intended for human

¿Qué debo hacer si tengo este producto?

Voluntary: Firm initiated · Press Release